CRISPR Therapeutics AG (CRSP)

60.09 -0.05 (-0.08%) USD  |  NASDAQ  |  Mar 02, 13:52
More

CRISPR Therapeutics Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
EvoNext Holdings SA --
Kuros Biosciences Ltd. --

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow to Firm (Quarterly) Upgrade
Free Cash Flow Yield Upgrade